Regulation of CD4 T-cell receptor diversity by vaccine adjuvants

Immunology

Volumn 130, Issue 1, 2010, Pages 16-22

  Baumgartner, Christina K ^a   Malherbe, Laurent P ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

Adjuvant; CD4 T helper cells; Epitope; MHC class II; Repertoire selection

Indexed keywords

BCG VACCINE; CPG OLIGODEOXYNUCLEOTIDE; FREUND ADJUVANT; IMMUNOLOGICAL ADJUVANT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOSPHORYL LIPID A; T LYMPHOCYTE RECEPTOR;

ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; CD4+ T LYMPHOCYTE; CELL SELECTION; CLONAL VARIATION; CONFORMATIONAL TRANSITION; DRUG RECEPTOR BINDING; IMMUNOPOTENTIATION; IMMUNOPROPHYLAXIS; IMMUNOREGULATION; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; RECEPTORS, ANTIGEN, T-CELL; VACCINES;

EID: 77950487893     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03265.x     Document Type: Review

References (66)

1. Seder RA, Ahmed R. Similarities and differences in CD4(+) and CD8(+) effector and memory T cell generation. Nat Immunol 2003 4 : 835 842. (Pubitemid 37098653)
2. McHeyzer-Williams LJ, Malherbe LP, McHeyzer-Williams MG. Helper T cell-regulated B cell immunity. Curr Top Microbiol Immunol 2006 311 : 59 83.
3. Turner SJ, La Gruta NL, Kedzierska K, Thomas PG, Doherty PC. Functional implications of T cell receptor diversity. Curr Opin Immunol 2009 21 : 286 290.
4. Davis MM, Boniface JJ, Reich Z, Lyons D, Hampl J, Arden B, Chien YH. Ligand recognition by alpha beta T cell receptors. Annu Rev Immunol 1998 16 : 523 544.
5. Malherbe L, Hausl C, Teyton L, McHeyzer-Williams MG. Clonal selection of helper T cells is determined by an affinity threshold with no further skewing of TCR binding properties. Immunity 2004 21 : 669 679.
6. Pulendran B, Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell 2006 124 : 849 863.
7. Guy B. The perfect mix: recent progress in adjuvant research. Nat Rev Microbiol 2007 5 : 505 517.
8. Schijns V. Immunological concepts of vaccine adjuvant activity - commentary. Curr Opin Immunol 2000 12 : 456 463.
9. Cox JC, Coulter AR. Adjuvants - a classification and review of their modes of action. Vaccine 1997 15 : 248 256.
10. Lambrecht BN, Kool M, Willart MAM, Hammad H. Mechanism of action of clinically approved adjuvants. Curr Opin Immunol 2009 21 : 23 9.
11. De Gregorio E, D'Oro U, Wack A. Immunology of TLR-independent vaccine adjuvants. Curr Opin Immunol 2009 21 : 339 345.
12. Marrack P, McKee AS, Munks MW. Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol 2009 9 : 287 293.
13. Palm NW, Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol Rev 2009 227 : 221 233.
14. Pulendran B. Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol Rev 2004 199 : 227 250.
15. Garcon N, Chomez P, Van Mechelen M. GlaxoSmithKline Adjuvant systems in vaccines: concepts, achievements and perspectives. Expert Rev Vaccines 2007 6 : 723 739.
16. Casella CR, Mitchell TC. Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell Mol Life Sci 2008 65 : 3231 3240.
17. Reed SG, Bertholet S, Coler RN, Friede M. New horizons in adjuvants for vaccine development. Trends Immunol 2009 30 : 23 32.
18. Benacerraf B, McDevitt HO. Histocompatibility-linked immune response genes. Science 1972 175 : 273 279.
19. Berzofsky JA, Brett SJ, Streicher HZ, Takahashi H. Antigen processing for presentation to T lymphocytes: function, mechanisms, and implications for the T-cell repertoire. Immunol Rev 1988 106 : 5 31.
20. Hui GS, Chang SP, Gibson H, Hashimoto A, Hashiro C, Barr PJ, Kotani S. Influence of adjuvants on the antibody specificity to the Plasmodium falciparum major merozoite surface protein, gp195. J Immunol 1991 147 : 3935 3941.
21. Rawlings DJ, Kaslow DC. Adjuvant-dependent immune response to malarial transmission-blocking vaccine candidate antigens. J Exp Med 1992 176 : 1483 1487.
22. Sant AJ, Chaves FA, Jenks SA, Richards KA, Menges P, Weaver JM, Lazarski CA. The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II: peptide complexes. Immunol Rev 2005 207 : 261 278.
23. Lo-Man R, Langeveld JPM, Deriaud E et al. Extending the CD4(+) T-cell epitope specificity of the Th1 immune response to an antigen using a Salmonella enterica serovar Typhimurium delivery vehicle. Infect Immun 2000 68 : 3079 3089.
24. Bennekov T, Dietrich J, Rosenkrands I, Stryhn A, Doherty TM, Andersen P. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis. Eur J Immunol 2006 36 : 3346 3355.
25. Malherbe L, Mark L, Fazilleau N, McHeyzer-Williams LJ, McHeyzer-Williams MG. Vaccine adjuvants alter TCR-based selection thresholds. Immunity 2008 28 : 698 709.
26. Solinger AM, Ultee ME, Margoliash E, Schwartz RH. T-lymphocyte response to cytochrome c. I. Demonstration of a T-cell heteroclitic proliferative response and identification of a topographic antigenic determinant on pigeon cytochrome c whose immune recognition requires two complementing major histocompatibility complex-linked immune response genes. J Exp Med 1979 150 : 830 848.
27. McHeyzer-Williams MG, Davis MM. Antigen-specific development of primary and memory T cells in vivo. Science 1995 268 : 106 111.
28. McHeyzer-Williams LJ, Panus JF, Mikszta JA, McHeyzer-Williams MG. Evolution of antigen-specific T cell receptors in vivo: preimmune and antigen-driven selection of preferred complementarity-determining region 3 (CDR3) motifs. J Exp Med 1999 189 : 1823 1837.
29. Fremont DH, Dai SD, Chiang H, Crawford F, Marrack P, Kappler J. Structural basis of cytochrome c presentation by IEk. J Exp Med 2002 195 : 1043 1052.
30. Krogsgaard M, Prado N, Adams EJ, He XL, Chow DC, Wilson DB, Garcia KC, Davis MM. Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. Mol Cell 2003 12 : 1367 1378.
31. Baumgartner CK, Ferrante A, Nagaoka M, Gorski J, Malherbe LP. Peptide-MHC Class II Complex Stability Governs CD4 T Cell Clonal Selection. J Immunol 2010 184 : 573 581.
32. Blander JM, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006 440 : 808 812.
33. Yarovinsky F, Kanzler H, Hieny S, Coffman RL, Sher A. Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4(+) T cell response. Immunity 2006 25 : 655 664.
34. Joffre O, Nolte MA, Sporri R, Sousa CRE. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol Rev 2009 227 : 234 247.
35. Longhi MP, Trumpfheller C, Idoyaga J et al. Dendritic cells require a systemic type I interferon response to mature and induce CD4(+) Th1 immunity with poly IC as adjuvant. J Exp Med 2009 206 : 1589 1602.
36. Drakesmith H, O'Neil D, Schneider SC, Binks M, Medd P, Sercarz E, Beverley P, Chain B. In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen. Proc Natl Acad Sci USA 1998 95 : 14903 14908.
37. Kitamura H, Kamon H, Sawa SI, Park SJ, Katunuma N, Ishihara K, Murakami M, Hirano T. IL-6-STAT3 controls intracellular MHC class II alpha beta dimer level through cathepsin S activity in dendritic cells. Immunity 2005 23 : 491 502.
38. Fiebiger E, Meraner P, Weber E, Fang IF, Stingl G, Ploegh H, Maurer D. Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J Exp Med 2001 193 : 881 892.
39. Kuhns MS, Epshteyn V, Sobel RA, Allison LP. Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4(+) T cells. Proc Natl Acad Sci USA 2000 97 : 12711 12716.
40. Egen JG, Allison JP. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 2002 16 : 23 35.
41. Yang SX, Hodge JW, Grosenbach DW, Schlom J. Vaccines with enhanced costimulation maintain high avidity memory CTL. J Immunol 2005 175 : 3715 3723.
42. Hodge JW, Chakraborty M, Kudo-Saito C, Garnett CT, Schlom J. Multiple costimulatory modalities enhance CTL avidity. J Immunol 2005 174 : 5994 6004.
43. Oh S, Hodge JW, Ahlers JD, Burke DS, Schlom J, Berzofsky JA. Selective induction of high avidity CTL by altering the balance of signals from APC. J Immunol 2003 170 : 2523 2530.
44. Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, Rudensky AY, Jenkins MK. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 2003 19 : 47 57.
45. Allenspach EJ, Lemos MP, Porrett PM, Turka LA, Laufer TM. Migratory and Lymphoid-Resident Dendritic Cells Cooperate to Efficiently Prime Naive CD4 T cells. Immunity 2008 29 : 795 806.
46. Kool M, Soullie T, van Nimwegen M et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med 2008 205 : 869 882.
47. Nakano H, Lin KL, Yanagita M, Charbonneau C, Cook DN, Kakiuchi T, Gunn MD. Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses. Nat Immunol 2009 10 : 394 402.
48. Constant SL. B lymphocytes as antigen-presenting cells for CD4(+) T cell priming in vivo. J Immunol 1999 162 : 5695 5703.
49. Obst R, van Santen HM, Mathis D, Benoist I. Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response. J Exp Med 2005 201 : 1555 1565.
50. Obst R, van Santen HM, Melamed R, Kamphorst A, Benoist C, Mathis D. Sustained antigen presentation can promote an immunogenic T cell response, like dendritic cell activation. Proc Natl Acad Sci USA 2007 104 : 15460 15465.
51. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998 392 : 245 252.
52. Vidard L, Rock KL, Benacerraf B. Heterogeneity in antigen processing by different types of antigen-presenting cells. Effect of cell culture on antigen processing ability. J Immunol 1992 149 : 1905 1911.
53. Schneider SC, Sercarz EE. Antigen processing differences among APC. Hum Immunol 1997 54 : 148 158.
54. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 2005 23 : 975 1028.
55. Burster T, Beck A, Tolosa E et al. Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cells. J Immunol 2005 175 : 5940 5949.
56. Stoeckle C, Sommandas V, Adamopoulou E et al. Cathepsin G is differentially expressed in primary human antigen-presenting cells. Cell Immunol 2009 255 : 41 5.
57. Hornell TMC, Burster T, Jahnsen FL et al. Human dendritic cell expression of HLA-DO is subset specific and regulated by maturation. J Immunol 2006 176 : 3536 3547.
58. Chen XJ, Reed-Loisel LM, Karlsson L, Jensen PE. H2-O expression in primary dendritic cells. J Immunol 2006 176 : 3548 3556.
59. Robadey C, Wallny HJ, Demotz S. Cell type-specific processing of the I-Ed-restricted hen egg lysozyme determinant 107-116. Eur J Immunol 1996 26 : 1656 1659.
60. Gapin L, de Alba YB, Casrouge A, Cabaniols JP, Kourilsky P, Kanellopoulos J. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model. J Immunol 1998 160 : 1555 1564.
61. Herzog J, Maekawa Y, Cirrito TP, Illian BS, Unanue ER. Activated antigen-presenting cells select and present chemically modified peptides recognized by unique CD4 T cells. Proc Natl Acad Sci USA 2005 102 : 7928 7933.
62. Suri A, Lovitch SB, Unanue ER. The wide diversity and complexity of peptides bound to class II MHC molecules. Curr Opin Immunol 2006 18 : 70 7.
63. Ireland J, Herzog J, Unanue ER. Cutting edge: unique T cells that recognize citrullinated peptides are a feature of protein immunization. J Immunol 2006 177 : 1421 1425.
64. Lovitch SB, Unanue ER. Conformational isomers of a peptide-class II major histocompatibility complex. Immunol Rev 2005 207 : 293 313.
65. Lovitch SB, Esparza TJ, Schweitzer G, Herzog J, Unanue ER. Activation of type B T cells after protein immunization reveals novel pathways of in vivo presentation of peptides. J Immunol 2007 178 : 122 133.
66. Honda M, Wang R, Kong WP et al. Different Vaccine Vectors Delivering the Same Antigen Elicit CD8(+) T Cell Responses with Distinct Clonotype and Epitope Specificity. J Immunol 2009 183 : 2425 2434.